O4‐02‐03: RANDOMIZED TRIAL OF SUVOREXANT FOR TREATING INSOMNIA IN ALZHEIMER'S DISEASE: EFFECTS ON OBJECTIVE SLEEP MEASURES. (1st July 2019)